Aligos Therapeutics, Inc. Common Stock

ALGSNASDAQ • USD
ThemeBiotech - Drug Development›Infectious Disease & Vaccines
5.35 USD
↘ 0.06 (1.02%)🟢LIVE (AS OF 01:56 PM EDT)
🟢Market: OPEN

ALGS is currently priced at $5.35. Both sides of the analysis point lower: technicals flash "Strong Sell" and fundamentals confirm with a "Sell" reading. Notable factors include a concerning Altman Z-Score in the distress zone, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. The stock looks compelling on valuation, with multiples below sector averages across P/E, P/B, and EV/EBITDA.

Technical & fundamental data as of Oct 5, 2026.

Open?$5.46
High?$5.71
Low?$5.27
Prev. Close?$5.40
Volume?10.6K
Avg. Volume?51.1K
VWAP?$5.39
Rel. Volume?0.21x
Bid / Ask
Bid?$4.56 × 100
Ask?$6.21 × 100
Spread?$1.65
Midpoint?$5.39
Valuation & Ratios
Market Cap?33.7M
Shares Out?6.2M
Float?4.8M
Float %?89.2%
P/E Ratio?N/A
P/B Ratio?1.06
EPS?-$12.16
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Aligos Therapeutics Inc is a clinical-stage biotechnology company focused on developing therapeutics for liver diseases and viral infections. Its pipeline includes drug candidates targeting chronic hepatitis B virus (HBV) infection, metabolic dysfunction-associated steatohepatitis (MASH), obesity, and coronavirus infections, with programs such as pefivfoscorvir sodium for HBV, ALG-055009 for MASH and obesity, and ALG-097558 for coronavirus infections.
Themes
Biotech - Drug Development›Infectious Disease & VaccinesBiotech - Drug Development›Metabolic & Cardiometabolic
Employees
82
Market Cap
33.7M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
www.aligos.com
Listed
2020-10-16
Address
ONE CORPORATE DR., 2ND FLOOR
SOUTH SAN FRANCISCO, CA 94080
Phone: (800) 466-6059
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
40
Z-Score?
0
Momentum?
50
Short Sent.?
23
Piotroski F-Score?4/9Mixed
Altman Z-Score?-16.33Distress
Confidence?58%Low
Full Fundamental Analysis →
Short InterestVery High
Short % of Float?14.51%High
Short Interest?697.7K
Days to Cover?15.4
Free Float4.8M
Avg Daily Volume45.4K
Settlement Date2026-09-15
Financial Health
Current Ratio?2.19Strong
Quick Ratio?2.19Strong
Cash Ratio?1.07Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
100/100
P/E?
N/A▾
P/B?
Peers
100
S&P
97
1.06CHEAP▾
P/S?
Peers
100
S&P
85
1.07CHEAP▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-0.0CHEAP▾
EV/Sales?
Peers
100
S&P
97
0.11CHEAP▾
Returns & Efficiency
ROE?
S&P
3
-238.2%WEAK▾
ROA?
S&P
3
-114.5%WEAK▾
Cash Flow & Enterprise
FCF?$-94523000
Enterprise Value?$3.4M
Fundamentals ratios updated end of day
MarketsMoversWatchlist